Xcout Intel
Pikralida
Pikralida is a biotechnology and contract research organization located in Poland that combines research, development, and innovative formulation services to advance breakthrough therapeutics.
Subscribe to see Pikralida’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pikralida at a glance
Pikralida is a biotech company headquartered in Poland. Its most recent funding round closed in November 2025. Xcout tracks 6 named people at Pikralida, including dr Anna Krause, MBA (Współzałożycielka, członek zarządu i dyrektor ds. badań i rozwoju).
Pikralida leadership
- dr Anna Krause, MBAWspółzałożycielka, członek zarządu i dyrektor ds. badań i rozwoju
- dr Joanna LipnerWspółzałożycielka, członek zarządu i dyrektor zarządzająca
- dr Stanisław PikulWspółzałożyciel i prezes zarządu
- Karolina BrokowskaCzłonek rady nadzorczej
- Stanisław KnaflewskiCzłonek rady nadzorczej
- Urszula MikiewiczCzłonek rady nadzorczej
Pikralida funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Pikralida competitors
A few of Pikralida's closest competitors — see the full list of competitors and alternatives →
Gubra is a Danish biotech and contract research organization (CRO) specializing in preclinical peptide drug discovery, metabolic research, and advanced imaging services.
MycoRx LLC develops new antifungal drug candidates designed to overcome drug resistance and treat fungal infections ranging from recurrent skin conditions to life-threatening sepsis. The company also supports clinical trials for other drug developers and maintains safety standards in the testing and manufacturing of pharmaceutical products.
Sinotherapeutics Inc. is a high-tech pharmaceutical enterprise focused on the research, commercial production, and sales of advanced drug formulations, including anti-infective, anti-tumor, metabolic, and cardiovascular medications. The company also provides innovative drug formulation CRO and CMO services to global patients and pharmaceutical partners.
SFJ Pharmaceuticals is a privately held pharmaceutical development and investment company that helps advance drug candidates through clinical development and regulatory approval. It serves biotechnology and pharmaceutical partners by providing development funding, operational expertise, and global clinical-trial support.
Selvita is an integrated contract research organization that provides comprehensive drug discovery and development services to the pharmaceutical and biotechnology industries. The company supports projects from target validation through preclinical candidate nomination and clinical trial batch manufacturing, specializing in small molecules, biologics, and agroscience under GMP and GLP standards.
Mabion SA operates as a biotechnology company and Contract Development and Manufacturing Organization (CDMO) that provides services encompassing process development, analytics, and drug substance manufacturing. The company specializes in working with biologics such as biosimilars, antibodies, antibody-drug conjugates (ADCs), and recombinant therapeutic proteins to serve biopharmaceutical clients.
Get Pikralida's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Pikralida in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access